SynthesisJournal of oral & facial pain and headache2025
Prevalence of temporomandibular disorder in irritable bowel syndrome (IBS) patients: a systematic review.
Synthesis in Journal of oral & facial pain and headache, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimorbidity in Chronic Overlapping Pain Conditions: From Burden to Integrated Care.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTemporomandibular disorders (TMD) refer to a collection of pathological conditions that impact the stomatognathic system, often associated with psychiatric comorbidities. Interestingly, previous studies have reported a higher prevalence of TMD in individuals affected by irritable bowel syndrome (IBS), a condition commonly linked to stress-induced psychosomatic factors. The aim of this systematic review is to clarify the prevalence of TMD in IBS-diagnosed patients.
methodsA systematic search was conducted in PubMed, Scopus, Web of Science and Cochrane Library databases up to May 2024, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the Cochrane Handbook for Systematic Reviews of Interventions. Eligibility criteria included studies reporting prevalence data on TMD in IBS patients. Study quality was assessed using the Risk of Bias in Non-randomized Studies-of Exposure (ROBINS-E) tool.
resultsA total of five studies, involving 3138 patients, were included. TMD prevalence was significantly higher in IBS patients compared to pooled controls. However, no significant differences were observed among IBS subtypes regarding TMD prevalence.
conclusionsThis review highlights a substantially higher prevalence of TMD in IBS patients compared to the general population, suggesting a shared pathophysiological mechanism likely linked to stress response systems. These findings underscore the need for a multidisciplinary approach to patient management and emphasize the importance of further research to explore the causal links and underlying mechanisms between IBS and TMD. THE PROSPERO REGISTRATION: The protocol has been registered on the International Prospective Register of Systematic Reviews (PROSPERO) with the number CRD42024542233.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.